News Sore Thumb 2024-10-11 Sore Thumb 2024-10-11 JLSC President Contributes to NPC Institute’s Whitepaper Read More Sore Thumb 2024-04-08 Sore Thumb 2024-04-08 JLSC Founder appears as guest on NGBIdeas Podcast Read More Sore Thumb 2024-02-01 Sore Thumb 2024-02-01 Smithyes to interview new pCPA CEO, Douglas Clark Read More Sore Thumb 2024-01-22 Sore Thumb 2024-01-22 Proteocyte Welcomes Key Advisor Mark Smithyes as Strategic Advisor Read More Sore Thumb 2023-09-11 Sore Thumb 2023-09-11 Mark Smithyes presents at Sunnybrook’s Medventions 2023 Lecture Series Read More Sore Thumb 2022-11-11 Sore Thumb 2022-11-11 Mark Smithyes to Lead Life Sciences Practice Group as National Director Read More Sore Thumb 2022-11-08 Sore Thumb 2022-11-08 Toward a new era of LifeSci innovation Read More Sore Thumb 2022-11-02 Sore Thumb 2022-11-02 Advancing Tech in the Life Sciences and Consulting - Podcast Read More Sore Thumb 2022-10-04 Sore Thumb 2022-10-04 Blue-Zone Technologies, Ltd. Secures $8 Million of Institutional Financing Read More Sore Thumb 2022-05-26 Sore Thumb 2022-05-26 LSO 2022 Awards Presentations: Remarks, Mark Smithyes, Chair, Life Sciences Ontario Read More Sore Thumb 2021-11-15 Sore Thumb 2021-11-15 Nurosene Appoints Mark Smithyes as President of Wholly-Owned Subsidiary, Netramark, A Leading AI Pharmatech Company Read More Sore Thumb 2021-10-05 Sore Thumb 2021-10-05 Navigating today’s world of work through relationships Read More
Sore Thumb 2024-10-11 Sore Thumb 2024-10-11 JLSC President Contributes to NPC Institute’s Whitepaper Read More
Sore Thumb 2024-04-08 Sore Thumb 2024-04-08 JLSC Founder appears as guest on NGBIdeas Podcast Read More
Sore Thumb 2024-02-01 Sore Thumb 2024-02-01 Smithyes to interview new pCPA CEO, Douglas Clark Read More
Sore Thumb 2024-01-22 Sore Thumb 2024-01-22 Proteocyte Welcomes Key Advisor Mark Smithyes as Strategic Advisor Read More
Sore Thumb 2023-09-11 Sore Thumb 2023-09-11 Mark Smithyes presents at Sunnybrook’s Medventions 2023 Lecture Series Read More
Sore Thumb 2022-11-11 Sore Thumb 2022-11-11 Mark Smithyes to Lead Life Sciences Practice Group as National Director Read More
Sore Thumb 2022-11-02 Sore Thumb 2022-11-02 Advancing Tech in the Life Sciences and Consulting - Podcast Read More
Sore Thumb 2022-10-04 Sore Thumb 2022-10-04 Blue-Zone Technologies, Ltd. Secures $8 Million of Institutional Financing Read More
Sore Thumb 2022-05-26 Sore Thumb 2022-05-26 LSO 2022 Awards Presentations: Remarks, Mark Smithyes, Chair, Life Sciences Ontario Read More
Sore Thumb 2021-11-15 Sore Thumb 2021-11-15 Nurosene Appoints Mark Smithyes as President of Wholly-Owned Subsidiary, Netramark, A Leading AI Pharmatech Company Read More
Sore Thumb 2021-10-05 Sore Thumb 2021-10-05 Navigating today’s world of work through relationships Read More
